期刊文献+

中药复方AC_(960)对人肝癌细胞p21^(ras)、bal-2、P^(53)基因表达调控作用的研究 被引量:23

STUDY ON THE REGULATION EFFECT OF CHINESE HERBAL MEDICINE AC960 ON THE EXPRESSION OF P^(21)^(ras)、BAL-2 AND p^(53) IN HUMAN HEPATOMA CELL LINE SMMC-7721
暂未订购
导出
摘要 目的:研究中药复方AC960对人肝癌细胞基因、抑癌基因表达的影响,探讨其抗癌作用机制。方法:AC960灌胃给药后,采集大鼠血清,处理人肝癌细胞SMMC7721,3H-TdR掺入法观察细胞增殖,流式细胞仪分析细胞周期和p21ras、bal-2、P53基因蛋白表达。结果:AC960具有显著抑制 SMMC-7721细胞增殖和促进细胞凋亡作用,细胞周期分析,DNA直方图上见典型凋亡峰,24h时为21.25%,48h时为27.77%,早期(24h)S期细胞比例增加,G2/M期减少,后期(48h),Go/G1期细胞增多,S期减少。P53、bal-2、p21ras在 SMMC-7721细胞中都有不同程度表达,AC960处理后,P53表达增强,bcl-2、p21ras表达降低。结论:抑制癌基因、增强抑癌基因表达,阻断细胞增殖周期,抑制人肝癌细胞增殖,促进癌细胞凋亡可能是AC960抗肝癌主要作用机制。 Objective:To study the effects of AC960 on the expression of oncogene and tumor suppressor gene and investigate its anti - cancerous mechanism. Methods:Drugcontending serum was derived from rats orally pre-administered with AC960 through gastrogavage,and was added to subcultured humand hepatoma cells(SMMC-7721 )while the normal rat serum were as the control. Cell proliferation was measured with3H- TdR incorporation Cell apoptosis and expressions of P53,bcl- 2 and p21ras gene protein were analyzed with flow cytometry. Results: After treating with AC960,the inhibitory rate of3 H -TdR was 33.4% for 48h. There were tipical apoptotic peaks in DNA histigram,the apoptotic rate was 21 .25% for 24h,27.77% for 48h,AC960 arrested cell cycling at S- phrase at early and at G0/G1 phrase at later stage .Expression of p53 enhanced,but bal-2 and ras reduced. Conclusion:The inhibition of proliferation,induction of apooptosis via effect on the expression of onco- gene and tumor suppressor gene might be the man anti-hepatoma action mechanism of AC960.
出处 《中国中医药科技》 CAS 2000年第1期10-12,共3页 Chinese Journal of Traditional Medical Science and Technology
基金 上海市教委科技发展基金 上海市博士点建设基金资助项目
  • 相关文献

参考文献9

二级参考文献8

  • 1汤钊猷.肝癌临床研究的现状与展望[J].中华肝脏病杂志,1996,4(3):131-132. 被引量:6
  • 2袁淑兰,中华肿瘤杂志,1995年,17卷,6期,424页
  • 3傅兴生,中华病理学杂志,1993年,23卷,1期,50页
  • 4Wu W,Am J Chin Med,1991年,19卷,34期,207页
  • 5Lai CL.et al.Recombinant interferon-α in inoperable hepatocellualar carcinoma:Arandomized controlled trial.Hepaology,1993:7:389.
  • 6全国肿瘸病防治办公室、全国抗癌协会合编.中国常见恶性肿瘤诊治规范第九分册,北京:北京医科大学、中国协和医科大学联合出版社,1990.15.
  • 7胡月红,胡月娟,徐军,沈伟,张晓晨,邱纲.钱氏抗肝癌方的抗瘤实验研究[J].中成药,1997,19(4):34-35. 被引量:9
  • 8吴军正,司徒镇强,陈建元,刘斌,王为.粘液表皮样癌MEC-1系对常用抗肿瘤药的敏感性[J].实用口腔医学杂志,1990,6(4):320-321. 被引量:10

共引文献141

同被引文献371

引证文献23

二级引证文献110

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部